Science! SDU Researchers Identified the Membrane Receptor for Ceramide in Adipocytes
JINAN, China, March 26, 2025 /PRNewswire/ -- Recently, Professor Sun Jinpeng's team at Shandong University and collaborators published a research paper titled "Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis" in Science. This study employed high-throughput screening and animal models to identify FPR2, a G protein-coupled receptor (GPCR) expressed at the adipocyte plasma membrane, as a...
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
SHANGHAI, March 26, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced its financial results for the full year ended December 31, 2024, along with a corporate update. "In 2024, Everest continued to strength the execution of our...
Kelun-Biotech’s Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
CHENGDU, China, March 26, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a radionuclide-drug conjugate (RDC) drug SKB107 (formerly TBM-001) from the Center for Drug Evaluation of the National Medical Products Administration. SKB107 is the first company RDC drug clinical...
Fosun Pharma Announces 2024 Annual Results
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 26, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended 31 December 2024 ("the Reporting Period")....
Ping An Health Releases 2024 ESG Report
Driving Sustainable Healthcare with "CARE" Strategy HONG KONG and SHANGHAI, March 26, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health" or "the Company", Stock Code: 1833.HK) recently released its 2024 Environmental, Social, and Governance (ESG) Report, outlining the Company's CARE sustainability strategy built on the pillars of Comprehensive Sustainability, Advanced Technology Empowerment, Robust Information...
CStone to Showcase Five Latest Research Achievements at AACR 2025
SUZHOU, China, March 26, 2025 /PRNewswire/ -- From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place in Chicago. CStone will showcase its latest preclinical studies on five internally developed innovative candidates, including the trispecific antibody CS2009, the bispecific antibody CS2011, and three novel antibody-drug conjugates (ADCs) developed from CStone's proprietary...
Alma introduces Alma Harmony, a state-of-the-art aesthetic platform for next-level in-office treatments
Featuring a simply intelligence interface and substantial technological upgrades, the new multiplatform presents a new era in patient personalization CAESAREA, Israel, March 26, 2025 /PRNewswire/ -- Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, announced today the global debut of the latest edition of...
Complete Genomics Announces Commercial Partnership with Human Cell Atlas to Offer its Members Stereo-seq Spatial Transcriptomics at NextGen Omics & Spatial Biology Conference
SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atlas (HCA) to offer its STOmics spatial transcriptomics products to HCA members. Human Cell Atlas (HCA), an international collaborative research consortium, is mapping all cell types in...
Complete Genomics Announces Partnership with BioTuring and the Go Optical STOmics microscope.
SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has partnered with BioTuring, developer of advanced bioinformatics algorithms and software that enables rapid OMICS analysis, to offer researchers access to SpatialX, a powerful deep-learning tool for unified multi-technology spatial data analysis compatible with STOmics chemistries...
Kolmar Korea Develops World’s First Hybrid Composite Sunscreen, Leading the Global Suncare Market
SEOUL, South Korea, March 25, 2025 /PRNewswire/ -- Global Cosmetics ODM (Original Development Manufacturer) Kolmar Korea has achieved a groundbreaking milestone by developing the world's first hybrid composite sunscreen stabilization technology. This innovation seamlessly integrates the great UV protection of inorganic sunscreens with the superior spreadability of organic sunscreens. ...
